Abivax SA Financial Overview
Abivax SA's market cap is currently €6.87B. The company's EPS TTM is €-0.843; its P/E ratio is -31.59; Abivax SA is scheduled to report earnings on September 8, 2025, and the estimated EPS forecast is €-0.68. See an overview of income statement, balance sheet, and cash flow financials.
